Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK. (2022)
Attributed to:
Gene Editing in X-Linked Agammaglobulinaemia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cei/uxac008
PubMed Identifier: 35641155
Publication URI: http://europepmc.org/abstract/MED/35641155
Type: Journal Article/Review
Volume: 209
Parent Publication: Clinical and experimental immunology
Issue: 3
ISSN: 0009-9104